Advertisement
If you have a new account but are having problems posting or verifying your account, please email us on hello@boards.ie for help. Thanks :)
Hello all! Please ensure that you are posting a new thread or question in the appropriate forum. The Feedback forum is overwhelmed with questions that are having to be moved elsewhere. If you need help to verify your account contact hello@boards.ie

COVID-19: Vaccine/antidote and testing procedures Megathread [Mod Warning - Post #1]

15051535556325

Comments

  • Registered Users, Registered Users 2 Posts: 2,568 ✭✭✭XsApollo


    Thierry12 wrote: »
    Why such confidence in Oxford one?

    People do realise they are untested and a longshot?

    Adenoviral vaccines have been tried for 30 years and we have never got one to work effectively

    Oxford vaccine will be the first commercialy available adenoviral vaccine for humans in history

    I don’t have confidence it will work per say,
    More that they have done trials for Mers which didn’t have any side effects and SARS I think so they have had a head start as the vaccine is pretty similar to trials they have done on other coronas viruses which is why they were so quick.

    I read a few bits from Sarah Gilbert about it and the Mers vaccine they were doing.
    Something they didn’t change much in it so they are pretty sure the results would be the same.

    Anyway I’m no genius, just from reading her interviews about how they got where they are and stuff.


  • Registered Users, Registered Users 2 Posts: 12,149 ✭✭✭✭Gael23


    Bad news on. the treatment front this morning


  • Registered Users, Registered Users 2 Posts: 3,039 ✭✭✭Call me Al


    Gael23 wrote: »
    Bad news on. the treatment front this morning

    Care to expand?


  • Registered Users, Registered Users 2 Posts: 1,133 ✭✭✭Akabusi


    Gael23 wrote: »
    Bad news on. the treatment front this morning

    You're full of information.


  • Registered Users, Registered Users 2 Posts: 36,592 ✭✭✭✭LuckyLloyd


    Thanks for that ddarcy, interesting stuff.


  • Advertisement
  • Registered Users, Registered Users 2 Posts: 2,004 ✭✭✭Hmmzis


    Gael23 wrote: »
    Bad news on. the treatment front this morning

    Not all of them:

    https://www.medrxiv.org/content/10.1101/2020.08.26.20182444v1

    The key with CP as with any anti-viral therapy is early administration.


    Regarding Kevzara (and Tocilizumab). The IL-6 inhibitors were well worth a try, as IL-6 is the most elevated cytokine in severe cases. The trouble with the inhibition of it is that it makes people very susceptible to secondary infections, also there are other inflammatory agents that are highly elevated, so just taking out IL-6 can help, but it has its pitfalls as well. Overall, it turned out to not be improving outcomes in severe and critical cases.


  • Registered Users, Registered Users 2 Posts: 12,149 ✭✭✭✭Gael23


    Call me Al wrote: »
    Care to expand?

    Sanofi have abandoned trials of a treatment they were working on


  • Registered Users, Registered Users 2 Posts: 36,592 ✭✭✭✭LuckyLloyd


    Hmmzis wrote: »
    Not all of them:

    https://www.medrxiv.org/content/10.1101/2020.08.26.20182444v1

    The key with CP as with any anti-viral therapy is early administration.


    Regarding Kevzara (and Tocilizumab). The IL-6 inhibitors were well worth a try, as IL-6 is the most elevated cytokine in severe cases. The trouble with the inhibition of it is that it makes people very susceptible to secondary infections, also there are other inflammatory agents that are highly elevated, so just taking out IL-6 can help, but it has its pitfalls as well. Overall, it turned out to not be improving outcomes in severe and critical cases.

    How early is “early” in this instance? Is upon admission to hospital too early?


  • Registered Users, Registered Users 2 Posts: 2,004 ✭✭✭Hmmzis


    LuckyLloyd wrote: »
    How early is “early” in this instance? Is upon admission to hospital too early?

    In the Spanish trial it was a median of 8 days post symptom onset (7-9 days). In general, the earlier you get an antiviral into the patient the less damage the virus can do.

    When looking at the pathogenesis in a SARS-cov-2 infection, the early serocoversion is a tripping point to a severe disease. That usually happens within the first 10 days or so after symptom onset. If you can start the convalescent plasma (CP) or Remdesivir, or any other antiviral before that, the skewed humoral immune response can be remedied.


  • Registered Users, Registered Users 2 Posts: 29,044 ✭✭✭✭drunkmonkey


    Covid now a curable disease (don't shoot the messenger)

    A concept of curative retargeting has been found by cellular lockdown with kinase inhibitors from the oncologic pharmacopoiea.
    This means, virus replication can be stalled to zero w/o need of develpoment of new substances. There is no need for world
    vaccination anymore. The virus needs permissible cells, and most perimissible is phosphotyrosine on its own compnents.
    Paper is (not yet in PubMed) :
    http://coviki.org/cov/index.php?title=Unproven_ideas


  • Advertisement
  • Registered Users, Registered Users 2 Posts: 2,004 ✭✭✭Hmmzis


    Good to have it analyzed and written down in a proper study. Shows that the initial data about mutation rates was ballpark area correct and it's not mutating anywhere fast, thankfully.

    https://www.pnas.org/content/early/2020/08/28/2008281117


  • Registered Users, Registered Users 2 Posts: 2,004 ✭✭✭Hmmzis


    Covid now a curable disease (don't shoot the messenger)

    A concept of curative retargeting has been found by cellular lockdown with kinase inhibitors from the oncologic pharmacopoiea.
    This means, virus replication can be stalled to zero w/o need of develpoment of new substances. There is no need for world
    vaccination anymore. The virus needs permissible cells, and most perimissible is phosphotyrosine on its own compnents.
    Paper is (not yet in PubMed) :
    http://coviki.org/cov/index.php?title=Unproven_ideas

    Here is the actual paper:

    https://www.sciencedirect.com/science/article/pii/S1097276520305499?via%3Dihub

    It's a great finding and there a few cancer drugs outlined there that could help, especially omipalisib. The drugs are not cheap, but they can be had in pill form and at least for omipalisib the most notable side effect seems to be diarrhoea. This particular drug could also help with the fibrosis like injuries observed in a number of Covid-19 patients.

    Some limitations to the drugs and approach:

    1. They behave like antivirals, so need to be given early enough (see a few posts back for why)
    2. While the price is not prohibitive in a rich western country hospital, the 160+$ for a 2mg dose is quite a lot for poorer countries.
    3. Other factors I'm not even remotely qualified to assess


  • Registered Users, Registered Users 2 Posts: 8,859 ✭✭✭lawrencesummers


    Anybody got any idea of recent test turn around times in Cork?


  • Registered Users, Registered Users 2 Posts: 11,203 ✭✭✭✭hmmm


    Hmmzis wrote: »
    It's a great finding and there a few cancer drugs outlined there that could help, especially omipalisib.
    Mmmmm. Thanks for the analysis. Bleach kills Covid cells, we're not using it as a cure however.

    I think I'd prefer a simple once-off vaccine over having to take some complex and expensive cancer drug every time I have a sore throat. Now you're properly into potential side-effect territory.


  • Registered Users, Registered Users 2 Posts: 11,203 ✭✭✭✭hmmm


    https://www.cnbc.com/2020/09/01/us-advisors-recommend-four-phases-for-distributing-coronavirus-vaccine-nationwide.html

    "The vaccine would be distributed in four phases, with health-care workers and vulnerable Americans, like the elderly and those with underlying health conditions, getting it first, according to the group."

    "Phase two would include essential workers, teachers, homeless shelters as well as people in prisons, jails and detention centers. All older adults not included in phase one would be vaccinated in phase two. "

    "Phase three would include young adults, children and workers in industries “essential to the functioning of society” and who are at risk of exposure to the virus. About 85% to 95% of the country would be vaccinated by the end of phase three, according to the group. Phase four would include everyone not vaccinated yet. "


  • Closed Accounts Posts: 1,254 ✭✭✭LiquidZeb


    Just wondering what the lads here think of this article. According to Peter Hotez the dean of the National School of Tropical Medicine at Baylor College of Medicine, the earliest we'll see a vaccine is late 2021. Not sure what he knows that runs contrary to Oxford, Pfizer sinopharm etc but just wondering what ye think.

    https://magazine.jhsph.edu/2020/developing-vaccine-sars-cov-2


  • Registered Users, Registered Users 2 Posts: 3,981 ✭✭✭Diarmuid


    LiquidZeb wrote: »
    Just wondering what the lads here think of this article. According to Peter Hotez the dean of the National School of Tropical Medicine at Baylor College of Medicine, the earliest we'll see a vaccine is late 2021. Not sure what he knows that runs contrary to Oxford, Pfizer sinopharm etc but just wondering what ye think.

    https://magazine.jhsph.edu/2020/developing-vaccine-sars-cov-2

    That would hardly be surprising. This thread is good at keeping up to tabs on the latest news, but it's massively optimistic in regards to the time frames.


  • Moderators, Science, Health & Environment Moderators Posts: 14,648 Mod ✭✭✭✭marno21


    It seems to be always academics putting down the potential for a vaccine soon and the people who are actually working on the vaccine who maintain it'll be ready in 2020.

    Given the track record of academics in Irish media on matters related to covid-19 (not all of them, but some) I will maintain my optimism based on the interviews with those who actually are involved in the vaccine.


  • Registered Users, Registered Users 2 Posts: 1,928 ✭✭✭Marhay70


    hmmm wrote: »
    Mmmmm. Thanks for the analysis. Bleach kills Covid cells, we're not using it as a cure however.

    I think I'd prefer a simple once-off vaccine over having to take some complex and expensive cancer drug every time I have a sore throat. Now you're properly into potential side-effect territory.

    As the saying goes, "any port in a storm", I think I would go with whatever treatment is available and effective rather than wait for a vaccine which could be delayed for any number of reasons.


  • Registered Users, Registered Users 2 Posts: 11,203 ✭✭✭✭hmmm


    LiquidZeb wrote: »
    Just wondering what the lads here think of this article. According to Peter Hotez the dean of the National School of Tropical Medicine at Baylor College of Medicine, the earliest we'll see a vaccine is late 2021. Not sure what he knows that runs contrary to Oxford, Pfizer sinopharm etc but just wondering what ye think.
    What date is that article? I couldn't see it anywhere.

    Hotez is a proper expert on this, but his prediction of late 2021 is significantly later than many of his colleagues. It's all speculation anyway, we'll know in a few months.


  • Advertisement
  • Registered Users, Registered Users 2 Posts: 3,981 ✭✭✭Diarmuid


    marno21 wrote: »
    It seems to be always academics putting down the potential for a vaccine soon and the people who are actually working on the vaccine who maintain it'll be ready in 2020.

    Which of those two groups don't have skin in the game?


  • Registered Users, Registered Users 2 Posts: 12,149 ✭✭✭✭Gael23


    I think when it will be available on the market and when it will be widely available are two questions that each have a different answer.
    I have faith in the Oxford team that a significant breakthrough is within reach. The problem will be if they prioritise the UK for supply and come under pressure from the White House to deliver rapidly


  • Closed Accounts Posts: 1,254 ✭✭✭LiquidZeb


    hmmm wrote: »
    What date is that article? I couldn't see it anywhere.

    Hotez is a proper expert on this, but his prediction of late 2021 is significantly later than many of his colleagues. It's all speculation anyway, we'll know in a few months.

    I know the guardian had it on their live covid page at 3 this afternoon. Only got round to reading it this evening. John Hopkins Bloomberg Twitter page tweeted it 7 hours ago.


  • Registered Users, Registered Users 2 Posts: 9,710 ✭✭✭irishgeo


    i can see the vaccine for some vulnerable groups healthcare workers etc early 2021 and the rest of the population late 2021


  • Registered Users, Registered Users 2 Posts: 8,399 ✭✭✭Deeper Blue


    https://www.theatlantic.com/ideas/archive/2020/08/im-optimistic-that-we-will-have-a-covid-19-vaccine-soon/615811/

    I'm unsure if this was posted previously and apologies if so. Thought it was a good read, it's by a member of the Vaccine taskforce in Canada, he's optimistic of a vaccine by year end


  • Registered Users, Registered Users 2 Posts: 32,136 ✭✭✭✭is_that_so


    marno21 wrote: »
    It seems to be always academics putting down the potential for a vaccine soon and the people who are actually working on the vaccine who maintain it'll be ready in 2020.

    Given the track record of academics in Irish media on matters related to covid-19 (not all of them, but some) I will maintain my optimism based on the interviews with those who actually are involved in the vaccine.
    There's a natural caution built into some of them. Generally the caveat is best guess and of course not wanting to be called wildly optimistic. From reading, 2020 doesn't really look realistic given that it's September and Phase 3 for some of the front runners. Q1-Q2 2021 would be excellent, with the rest of us able to avail of it by winter 2021.


  • Registered Users, Registered Users 2 Posts: 2,004 ✭✭✭Hmmzis


    hmmm wrote: »
    Mmmmm. Thanks for the analysis. Bleach kills Covid cells, we're not using it as a cure however.

    I think I'd prefer a simple once-off vaccine over having to take some complex and expensive cancer drug every time I have a sore throat. Now you're properly into potential side-effect territory.

    Don't get me wrong, this one isn't a cure-all in any sense of it. It would still be a hospital only drug, but being in a pill form it could be a decent option, since Remdesivir is hard to make, it's IV only and supply is hard to come by. We would need anything that works at all.

    If it works out in a proper double blind clinical trial, then it's another option for hospitals to treat patients and cut down on the internal organ injuries and deaths. If it reduces hospital stay like Remdesivir, then even better.


  • Registered Users, Registered Users 2 Posts: 12,149 ✭✭✭✭Gael23


    is_that_so wrote: »
    There's a natural caution built into some of them. Generally the caveat is best guess and of course not wanting to be called wildly optimistic. From reading, 2020 doesn't really look realistic given that it's September and Phase 3 for some of the front runners. Q1-Q2 2021 would be excellent, with the rest of us able to avail of it by winter 2021.

    So nedt summer is cancelled as well then


  • Registered Users, Registered Users 2 Posts: 589 ✭✭✭ddarcy


    is_that_so wrote: »
    There's a natural caution built into some of them. Generally the caveat is best guess and of course not wanting to be called wildly optimistic. From reading, 2020 doesn't really look realistic given that it's September and Phase 3 for some of the front runners. Q1-Q2 2021 would be excellent, with the rest of us able to avail of it by winter 2021.

    There are a lot of things that need to be done once an approval is gained. They are not quick either. But if let’s say Astra Zeneca gets approval in mid-November. They will have to ramp up their production lines. This means ordering supplies / training/ quality control checks, etc. This needs to set up before a massive roll out.

    It could very well take 3-6 months after approval to get the lines fully operational. Plus this is hitting around Christmas, so I’d a difficult time of year to start these processes. Best guess is that initial vaccines will be available in March with full roll out by June. I can see some efficiencies to lowering times, so really high risk groups could see it by January/ February. I’d be shocked if there was a massive rollout this year.


  • Advertisement
  • Closed Accounts Posts: 1,254 ✭✭✭LiquidZeb


    ddarcy wrote: »
    There are a lot of things that need to be done once an approval is gained. They are not quick either. But if let’s say Astra Zeneca gets approval in mid-November. They will have to ramp up their production lines. This means ordering supplies / training/ quality control checks, etc. This needs to set up before a massive roll out.

    It could very well take 3-6 months after approval to get the lines fully operational. Plus this is hitting around Christmas, so I’d a difficult time of year to start these processes. Best guess is that initial vaccines will be available in March with full roll out by June. I can see some efficiencies to lowering times, so really high risk groups could see it by January/ February. I’d be shocked if there was a massive rollout this year.

    I think AZ and several of the other manufacturers have been producing vaccines for months at a potential loss. Hopefully this will mean supply can meet demand without any delays.


This discussion has been closed.
Advertisement